MEK1/2 inhibitors in the treatment of gynecologic malignancies.

@article{Miller2014MEK12II,
  title={MEK1/2 inhibitors in the treatment of gynecologic malignancies.},
  author={Caela R. Miller and Kate E. Oliver and John H. Farley},
  journal={Gynecologic oncology},
  year={2014},
  volume={133 1},
  pages={128-37}
}
Mitogen-activated protein kinases (MAPKs) are a family of ubiquitous eukaryotic signal transduction enzymes which link extracellular stimuli to intracellular gene expression pathways. While several three-tiered MAPK cascades have been elucidated in mammals, the prototypical pathway involves a network of proteins and kinases including the Rat sarcoma protein (Ras), mitogen-activated protein kinase kinase kinase (Raf or MAP3K), mitogen-activated protein kinase kinase (MEK or MAP2K), and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 35 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 61 references

Similar Papers

Loading similar papers…